Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 121

1.

Expression of endogenous hypoxia markers in vulvar squamous cell carcinoma.

Li YZ, Li SL, Li X, Wang LJ, Wang JL, Xu JW, Wu ZH, Gong L, Zhang XD.

Asian Pac J Cancer Prev. 2012;13(8):3675-80.

2.

Hemoglobin level predicts outcome for vulvar cancer patients independent of GLUT-1 and CA-IX expression in tumor tissue.

van de Nieuwenhof HP, de Hullu JA, Kaanders JH, Bulten J, Massuger LF, van Kempen LC.

Virchows Arch. 2010 Dec;457(6):693-703. doi: 10.1007/s00428-010-0981-x. Epub 2010 Oct 2.

3.

GLUT-1 expression is largely unrelated to both hypoxia and the Warburg phenotype in squamous cell carcinomas of the vulva.

Mayer A, Schmidt M, Seeger A, Serras AF, Vaupel P, Schmidberger H.

BMC Cancer. 2014 Oct 12;14:760. doi: 10.1186/1471-2407-14-760.

4.

Immunohistochemical detection of osteopontin in advanced head-and-neck cancer: prognostic role and correlation with oxygen electrode measurements, hypoxia-inducible-factor-1alpha-related markers, and hemoglobin levels.

Bache M, Reddemann R, Said HM, Holzhausen HJ, Taubert H, Becker A, Kuhnt T, Hänsgen G, Dunst J, Vordermark D.

Int J Radiat Oncol Biol Phys. 2006 Dec 1;66(5):1481-7. Epub 2006 Oct 23.

PMID:
17056190
5.

Immunohistochemical analysis of p53 in vulval intraepithelial neoplasia and vulval squamous cell carcinoma.

Rosenthal AN, Hopster D, Ryan A, Jacobs IJ.

Br J Cancer. 2003 Jan 27;88(2):251-6.

6.

Overexpression of carbonic anhydrase and HIF-1α in Wilms tumours.

Dungwa JV, Hunt LP, Ramani P.

BMC Cancer. 2011 Sep 12;11:390. doi: 10.1186/1471-2407-11-390.

8.

Increased osteopontin expression is associated with progression from vulvar precancerous lesions to vulvar squamous cell carcinoma.

Wu Z, Shen Y, Gong K, Wu Z, Zhang T, Zhang X, Li S.

Arch Gynecol Obstet. 2014 Mar;289(3):637-44. doi: 10.1007/s00404-013-3009-3. Epub 2013 Aug 25.

PMID:
23978873
9.

Human papillomavirus infection and p16(INK4a) protein expression in vulvar intraepithelial neoplasia and invasive squamous cell carcinoma.

Rufforny I, Wilkinson EJ, Liu C, Zhu H, Buteral M, Massoll NA.

J Low Genit Tract Dis. 2005 Apr;9(2):108-13.

PMID:
15870532
10.

HIF-1α and CA-IX as predictors of locoregional control for determining the optimal treatment modality for early-stage laryngeal carcinoma.

Kwon OJ, Park JJ, Ko GH, Seo JH, Jeong BK, Kang KM, Woo SH, Kim JP, Hwa JS, Carey TE.

Head Neck. 2015 Apr;37(4):505-10. doi: 10.1002/hed.23620. Epub 2014 Apr 9.

11.

Coexpression of hypoxia-inducible factors 1alpha and 2alpha, carbonic anhydrase IX, and vascular endothelial growth factor in nasopharyngeal carcinoma and relationship to survival.

Hui EP, Chan AT, Pezzella F, Turley H, To KF, Poon TC, Zee B, Mo F, Teo PM, Huang DP, Gatter KC, Johnson PJ, Harris AL.

Clin Cancer Res. 2002 Aug;8(8):2595-604.

12.

Overexpression of intrinsic hypoxia markers HIF1alpha and CA-IX predict for local recurrence in stage T1-T2 glottic laryngeal carcinoma treated with radiotherapy.

Schrijvers ML, van der Laan BF, de Bock GH, Pattje WJ, Mastik MF, Menkema L, Langendijk JA, Kluin PM, Schuuring E, van der Wal JE.

Int J Radiat Oncol Biol Phys. 2008 Sep 1;72(1):161-9. doi: 10.1016/j.ijrobp.2008.05.025.

PMID:
18722267
13.

Expression patterns of hypoxic markers at the invasive margin of colorectal cancers and liver metastases.

Rajaganeshan R, Prasad R, Guillou PJ, Scott N, Poston G, Jayne DG.

Eur J Surg Oncol. 2009 Dec;35(12):1286-94. doi: 10.1016/j.ejso.2009.05.008. Epub 2009 Jun 21.

PMID:
19540709
14.

The prognostic value of endogenous hypoxia-related markers for head and neck squamous cell carcinomas treated with ARCON.

Jonathan RA, Wijffels KI, Peeters W, de Wilde PC, Marres HA, Merkx MA, Oosterwijk E, van der Kogel AJ, Kaanders JH.

Radiother Oncol. 2006 Jun;79(3):288-97. Epub 2006 May 26.

PMID:
16730088
15.

Expression of vascular endothelial growth factor (VEGF) in vulvar squamous cancer and VIN.

Lewy-Trenda I, Wierzchniewska-ławska A, Papierz W.

Pol J Pathol. 2005;56(1):5-8.

PMID:
15921007
16.

The prognostic value of hypoxia markers in T2-staged oral tongue cancer.

Roh JL, Cho KJ, Kwon GY, Ryu CH, Chang HW, Choi SH, Nam SY, Kim SY.

Oral Oncol. 2009 Jan;45(1):63-8. doi: 10.1016/j.oraloncology.2008.03.017. Epub 2008 Jul 11.

PMID:
18620902
17.

Prognostic assessment of hypoxia and metabolic markers in cervical cancer using automated digital image analysis of immunohistochemistry.

Kim BW, Cho H, Chung JY, Conway C, Ylaya K, Kim JH, Hewitt SM.

J Transl Med. 2013 Aug 8;11:185. doi: 10.1186/1479-5876-11-185.

18.

Necrosis degree displayed in computed tomography images correlated with hypoxia and angiogenesis in breast cancer.

Shan X, Wang D, Chen J, Xiao X, Jiang Y, Wang Y, Fan Y.

J Comput Assist Tomogr. 2013 Jan-Feb;37(1):22-8. doi: 10.1097/RCT.0b013e318279abd1.

PMID:
23321829
19.

Is the hypoxia-inducible factor pathway important in gastric cancer?

Griffiths EA, Pritchard SA, Welch IM, Price PM, West CM.

Eur J Cancer. 2005 Dec;41(18):2792-805. Epub 2005 Nov 14. Review.

PMID:
16290133
20.

HIF-1alpha and CA IX staining in invasive breast carcinomas: prognosis and treatment outcome.

Trastour C, Benizri E, Ettore F, Ramaioli A, Chamorey E, Pouysségur J, Berra E.

Int J Cancer. 2007 Apr 1;120(7):1451-8.

Supplemental Content

Support Center